Impact of treatment duration of extended adjuvant therapy with neratinib in early stage HER2+HR+ breast cancer after trastuzumab-based therapy on patient outcomes
| Autor: | Martin Jimenez, M., Gnant, M. I., Ejlertsen, B., Mansi, J. L., Ruiz-Borrego, M., Jakobsen, E. H., Osborne, C. K., Birhiray, R., Zhang, B., Wong, A., Moy, B., Holmes, F. A. |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Zdroj: | Martin Jimenez, M, Gnant, M I, Ejlertsen, B, Mansi, J L, Ruiz-Borrego, M, Jakobsen, E H, Osborne, C K, Birhiray, R, Zhang, B, Wong, A, Moy, B & Holmes, F A 2020, ' Impact of treatment duration of extended adjuvant therapy with neratinib in early stage HER2+HR+ breast cancer after trastuzumab-based therapy on patient outcomes ', Annals of Oncology, vol. 31, no. Suppl. 2, pp. S43 . https://doi.org/10.1016/j.annonc.2020.03.023 |
| DOI: | 10.1016/j.annonc.2020.03.023 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|